Slate Bio

Charlottesville, United States

Slate Bio is an immunotherapeutics development company that develops therapeutic solutions for autoimmune diseases.

$2.8M raised

Jan 2023

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Slate Bio raised?

Slate Bio has raised $2.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.

Who are Slate Bio's investors?

Slate Bio's investors include Epidarex Capital, Virginia Venture Partners, PharmaDirections, UVA Licensing & Ventures Group, VTC Seed Fund.

Where is Slate Bio headquartered?

Slate Bio is headquartered in Charlottesville, United States.

What does Slate Bio do?

Slate Bio is an immunotherapeutics development company that develops therapeutic solutions for autoimmune diseases.

What stage is Slate Bio at?

Slate Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 17, 2023.

MLA

"Slate Bio — Funding & Investors." VCBacked, January 17, 2023, https://www.vcbacked.co/company/slate-bio. Accessed July 2, 2026.

APA

VCBacked. (2023). Slate Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/slate-bio

Wikipedia (cite web)

{{cite web |title=Slate Bio — Funding & Investors |url=https://www.vcbacked.co/company/slate-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 17, 2023.